CoChat

Interleukin-1α associates with the tumor suppressor p53 following DNA damage

Open access
Novak, J., Zamostna, B., Vopalensky, V., Buryskova, M., Burysek, L., Doleckova, D., Pospisek, M. · 2020 · Scientific Reports

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Abstract

Interleukin-1α (IL-1α) is a dual-function proinflammatory mediator. In addition to its role in the canonical IL-1 signaling pathway, which employs membrane-bound receptors, a growing body of evidence shows that IL-1α has some additional intracellular functions. We identified the interaction of IL-1α with the tumor suppressor p53 in the nuclei and cytoplasm of both malignant and noncancerous mammalian cell lines using immunoprecipitation and the in situ proximity ligation assay (PLA). This interaction was enhanced by treatment with the antineoplastic drug etoposide, which suggests a role for the IL-1α•p53 interaction in genotoxic stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-63779-x

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Colocalization of IL-1α and p53 in A375 cells. Endogenous IL-1α (red) and p53 (green) were visualized by indirect immunofluorescence in untreated A375 cells. Nuclei were stained with DAPI. IL-1α localized in both the cytoplasm and cell nucleus, while p53 was present mainly in the cell nucleus. Both proteins were mostly absent from nucleoli. The intensity profile shows the fluorescence intensity of both labeled proteins in the region delineated by the yellow line. Regions showing remarkable colocalization of p53 and IL-1α are marked with arrows. Distance is depicted in pixels. The intensity profile shows overlap of the green and red signals in both the nucleus and cytoplasm. Images were captured with a Zeiss LSM 880 confocal microscope; the scale bar represents 20 µm.
Figure 1 Colocalization of IL-1α and p53 in A375 cells. Endogenous IL-1α (red) and p53 (green) were visualized by indirect immunofluorescence in untreated A375 cells. Nuclei were stained with DAPI. IL-1α localized in both the cytoplasm and cell nucleus, while p53 was present mainly in the cell nucleus. Both proteins were mostly absent from nucleoli. The intensity profile shows the fluorescence intensity of both labeled proteins in the region delineated by the yellow line. Regions showing remarkable colocalization of p53 and IL-1α are marked with arrows. Distance is depicted in pixels. The intensity profile shows overlap of the green and red signals in both the nucleus and cytoplasm. Images were captured with a Zeiss LSM 880 confocal microscope; the scale bar represents 20 µm.CC BY · PubMed Central
Figure 2 Coimmunoprecipitation of IL-1α and p53. (a) A375 cells were transiently cotransfected with plasmids encoding Flag-tagged IL-1α (IL-1α/Flag) and EGFP-tagged p53 (p53/EGFP). Coimmunoprecipitation (IP) was performed using anti-EGFP antibody and transiently produced full-length IL-1α/Flag was detected with anti-Flag antibody; (b) the membrane was stripped and p53/EGFP was detected with CM-1 anti-p53 antibody. (c) The same experiment was performed in Mrc-5 cells, except that coimmunoprecipitation was performed with anti-Flag antibody. Mouse monoclonal anti-Flag and anti-p53 antibodies were used for the simultaneous detection of full-length IL-1α/Flag and p53/EGFP, respectively. Mock IP was performed in cells not expressing the respective bait. Each panel (a–c) corresponds to a single WB membrane. Asterisks represent antibody heavy and light chains. Numbers correspond to the MW of protein standards. Full size records from these membranes are available in Supplementary Fig. 5.
Figure 2 Coimmunoprecipitation of IL-1α and p53. (a) A375 cells were transiently cotransfected with plasmids encoding Flag-tagged IL-1α (IL-1α/Flag) and EGFP-tagged p53 (p53/EGFP). Coimmunoprecipitation (IP) was performed using anti-EGFP antibody and transiently produced full-length IL-1α/Flag was detected with anti-Flag antibody; (b) the membrane was stripped and p53/EGFP was detected with CM-1 anti-p53 antibody. (c) The same experiment was performed in Mrc-5 cells, except that coimmunoprecipitation was performed with anti-Flag antibody. Mouse monoclonal anti-Flag and anti-p53 antibodies were used for the simultaneous detection of full-length IL-1α/Flag and p53/EGFP, respectively. Mock IP was performed in cells not expressing the respective bait. Each panel (a–c) corresponds to a single WB membrane. Asterisks represent antibody heavy and light chains. Numbers correspond to the MW of protein standards. Full size records from these membranes are available in Supplementary Fig. 5.CC BY · PubMed Central
Figure 3 In situ proximity ligation assay (PLA) indicates the close colocalization of p53 with IL-1αNTP and IL-1α in U2OS cells. (a) U2OS were transfected with expression plasmid encoding fusion IL-1αNTP/EGFP protein (green captions and signals). PLA foci (red) developed both in nuclei and in the cytoplasm of transfected cells treated simultaneously with anti-GFP and anti-p53 (CM-1) antibodies. PLAs in transfected cells treated with single antibody or in untransfected cells treated with anti-GFP and anti-p53 together did not develop any signal and served as negative controls. (b) PLA with anti-p53 and anti-GFP antibodies was performed in U2OS cells which were transfected with expression plasmid encoding the full-length IL-1α/EGFP fusion protein and then treated with 20 μM roscovitine for 24 hours. Similarly to IL-1αNTP, the putative full-length IL-1α- and p53-containing complexes were distributed across nuclei and the cytoplasm. PLA in transfected cells using simultaneous application of anti-FLAG and anti-p53 was used as another negative control for both experiments depicted in (a,b) panels. Images were acquired with an Olympus Cell-R wide-field microscope. Scale bars represent 20 μm.
Figure 3 In situ proximity ligation assay (PLA) indicates the close colocalization of p53 with IL-1αNTP and IL-1α in U2OS cells. (a) U2OS were transfected with expression plasmid encoding fusion IL-1αNTP/EGFP protein (green captions and signals). PLA foci (red) developed both in nuclei and in the cytoplasm of transfected cells treated simultaneously with anti-GFP and anti-p53 (CM-1) antibodies. PLAs in transfected cells treated with single antibody or in untransfected cells treated with anti-GFP and anti-p53 together did not develop any signal and served as negative controls. (b) PLA with anti-p53 and anti-GFP antibodies was performed in U2OS cells which were transfected with expression plasmid encoding the full-length IL-1α/EGFP fusion protein and then treated with 20 μM roscovitine for 24 hours. Similarly to IL-1αNTP, the putative full-length IL-1α- and p53-containing complexes were distributed across nuclei and the cytoplasm. PLA in transfected cells using simultaneous application of anti-FLAG and anti-p53 was used as another negative control for both experiments depicted in (a,b) panels. Images were acquired with an Olympus Cell-R wide-field microscope. Scale bars represent 20 μm.CC BY · PubMed Central
Figure 4 In situ proximity ligation assay (PLA) indicates the close colocalization of endogenous IL-1α and p53 in A375 cells. The localization of either IL-1α or p53 (both in green) was detected using indirect immunofluorescence microscopy together with PLA, which revealed foci in which p53 and IL-1α appeared in close proximity to each other (red). (a) The interaction of IL-1α and p53 was visualized by PLA without the additional staining of endogenous proteins; (b) negative PLA control using anti-GFP antibody instead of anti-IL-1α antibody without the additional staining of endogenous proteins; (c) PLA with the staining of endogenous IL-1α. The nucleocytoplasmic distribution of both IL-1α and the PLA signal is clearly visible. (d) PLA was performed with staining for endogenous p53. The majority of the p53 protein localized to cell nuclei; however, a fraction of p53 was still present in the cytoplasm. PLA signal documenting the interaction between p53 and IL-1α is present in both the nucleus and cytoplasm. Images were captured with a Zeiss LSM 880 confocal microscope, and scale bars represent 20 µm. “no sec”. means that no secondary antibody was added to simultaneously label either endogenous p53 or IL-1α.
Figure 4 In situ proximity ligation assay (PLA) indicates the close colocalization of endogenous IL-1α and p53 in A375 cells. The localization of either IL-1α or p53 (both in green) was detected using indirect immunofluorescence microscopy together with PLA, which revealed foci in which p53 and IL-1α appeared in close proximity to each other (red). (a) The interaction of IL-1α and p53 was visualized by PLA without the additional staining of endogenous proteins; (b) negative PLA control using anti-GFP antibody instead of anti-IL-1α antibody without the additional staining of endogenous proteins; (c) PLA with the staining of endogenous IL-1α. The nucleocytoplasmic distribution of both IL-1α and the PLA signal is clearly visible. (d) PLA was performed with staining for endogenous p53. The majority of the p53 protein localized to cell nuclei; however, a fraction of p53 was still present in the cytoplasm. PLA signal documenting the interaction between p53 and IL-1α is present in both the nucleus and cytoplasm. Images were captured with a Zeiss LSM 880 confocal microscope, and scale bars represent 20 µm. “no sec”. means that no secondary antibody was added to simultaneously label either endogenous p53 or IL-1α.CC BY · PubMed Central
Figure 5 Effect of etoposide treatment on the p53•IL-1α interaction, as detected by in situ proximity ligation assay (PLA). PLA was performed with mouse anti-IL-1α and rabbit anti-p53 antibodies in U2OS cells treated with 10 μg/ml etoposide for two hours (n = 364) or control untreated cells (n = 321). (a) Representative fluorescence microscopy images used for subsequent analysis of the PLA intensity in nuclei and to compute In; etoposide-treated cells show a considerably higher PLA intensity in their nuclei in comparison with untreated cells. (b) PLA intensities in the nuclei of cells treated with etoposide were higher than those in untreated cells. The statistical significance of the results was evaluated by Fisher’s exact test (***p < 0.001); error bars represent 95% confidence intervals calculated by the adjusted Wald method. (c) Mean PLA fluorescence intensities over all pixels within individual nuclei (In) were determined for all cells and normalized to respective median In in the given biological replicate. The numbers of nuclei whose normalized In values fell into discrete intervals were plotted as a histogram. The PLA fluorescence was detected with a wide-field Olympus Cell-R microscope, and the scale bars represent 20 µm. Images were processed in ImageJ with a macro described in the Supplementary methods to determine the mean fluorescence intensity of each nucleus. Data were collected from three independent biological replicates. Primary data and all calculations are present in the Supplementary Data File.
Figure 5 Effect of etoposide treatment on the p53•IL-1α interaction, as detected by in situ proximity ligation assay (PLA). PLA was performed with mouse anti-IL-1α and rabbit anti-p53 antibodies in U2OS cells treated with 10 μg/ml etoposide for two hours (n = 364) or control untreated cells (n = 321). (a) Representative fluorescence microscopy images used for subsequent analysis of the PLA intensity in nuclei and to compute In; etoposide-treated cells show a considerably higher PLA intensity in their nuclei in comparison with untreated cells. (b) PLA intensities in the nuclei of cells treated with etoposide were higher than those in untreated cells. The statistical significance of the results was evaluated by Fisher’s exact test (***p < 0.001); error bars represent 95% confidence intervals calculated by the adjusted Wald method. (c) Mean PLA fluorescence intensities over all pixels within individual nuclei (In) were determined for all cells and normalized to respective median In in the given biological replicate. The numbers of nuclei whose normalized In values fell into discrete intervals were plotted as a histogram. The PLA fluorescence was detected with a wide-field Olympus Cell-R microscope, and the scale bars represent 20 µm. Images were processed in ImageJ with a macro described in the Supplementary methods to determine the mean fluorescence intensity of each nucleus. Data were collected from three independent biological replicates. Primary data and all calculations are present in the Supplementary Data File.CC BY · PubMed Central
Figure 6 Etoposide treatment increases intracellular levels of the p53 protein in U2OS and A375 cells. Serial dilutions of cell lysates (load) from untreated cells and cells treated with 10 µg/ml etoposide for two hours were analyzed by western blotting. Membranes were developed with anti-β-actin and anti-p53 (DO-1) antibodies. Numbers on the side correspond to the protein MW ladder.
Figure 6 Etoposide treatment increases intracellular levels of the p53 protein in U2OS and A375 cells. Serial dilutions of cell lysates (load) from untreated cells and cells treated with 10 µg/ml etoposide for two hours were analyzed by western blotting. Membranes were developed with anti-β-actin and anti-p53 (DO-1) antibodies. Numbers on the side correspond to the protein MW ladder.CC BY · PubMed Central
Figure 7 Endogenous IL-1α and p53 coimmunoprecipitate from U2OS cells upon etoposide treatment. Cells were either treated with etoposide (10 µg/ml, 2 hours, +eto) or left untreated (-eto). Coimmunoprecipitation (IP) was performed with anti-p53 antibody (CM-1) and resulting protein samples were split and analysed for IL-1α and p53 content by western blotting in parallel. The IL-1α-specific band is clearly visible in IP from etoposide-treated cells. Asterisk marks an antibody heavy chain. Numbers on the side correspond to the protein MW ladder. Mock IPs were performed from the same amount of the corresponding lysates without adding the CM-1 antibody. For the full-size membrane records we refer to the Supplementary Fig. 7a,b. Similar results we obtained also from A375 cells (Supplementary Fig. 7c). Supplementary Fig. 8 documents efficient imunoprecipitation of the p53 protein from the lysates.
Figure 7 Endogenous IL-1α and p53 coimmunoprecipitate from U2OS cells upon etoposide treatment. Cells were either treated with etoposide (10 µg/ml, 2 hours, +eto) or left untreated (-eto). Coimmunoprecipitation (IP) was performed with anti-p53 antibody (CM-1) and resulting protein samples were split and analysed for IL-1α and p53 content by western blotting in parallel. The IL-1α-specific band is clearly visible in IP from etoposide-treated cells. Asterisk marks an antibody heavy chain. Numbers on the side correspond to the protein MW ladder. Mock IPs were performed from the same amount of the corresponding lysates without adding the CM-1 antibody. For the full-size membrane records we refer to the Supplementary Fig. 7a,b. Similar results we obtained also from A375 cells (Supplementary Fig. 7c). Supplementary Fig. 8 documents efficient imunoprecipitation of the p53 protein from the lysates.CC BY · PubMed Central
Figure 8 Etoposide did not induce colocalization of IL-1α and γ-H2AX in the nucleus of U2OS cells. Cells were treated with etoposide (10 µg/ml, 2 hours) or left untreated. Upper panels show staining for endogenous γ-H2AX (red) and IL-1α (green); lower panels demonstrate staining for endogenous γ-H2AX (red) and p53 (green). Nuclei were stained with DAPI. The intensity profiles show the fluorescence intensity of both labeled proteins in the regions delineated by white lines. Etoposide increases relocalization of IL-1α into cell nuclei and induces formation of both IL-1α and γ-H2AX foci. Arrows above the white line in the γ–H2AX and IL-1α merge image and above the corresponding intensity profile show larger IL-1α foci depleted of the γ-H2AX signal. Images were captured with a Leica SP8 confocal microscope. Scale bars represent 20 µm.
Figure 8 Etoposide did not induce colocalization of IL-1α and γ-H2AX in the nucleus of U2OS cells. Cells were treated with etoposide (10 µg/ml, 2 hours) or left untreated. Upper panels show staining for endogenous γ-H2AX (red) and IL-1α (green); lower panels demonstrate staining for endogenous γ-H2AX (red) and p53 (green). Nuclei were stained with DAPI. The intensity profiles show the fluorescence intensity of both labeled proteins in the regions delineated by white lines. Etoposide increases relocalization of IL-1α into cell nuclei and induces formation of both IL-1α and γ-H2AX foci. Arrows above the white line in the γ–H2AX and IL-1α merge image and above the corresponding intensity profile show larger IL-1α foci depleted of the γ-H2AX signal. Images were captured with a Leica SP8 confocal microscope. Scale bars represent 20 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 87 references

Research works printed but not linked: 1

  1. Nicoll, J. A. et al. Association of interleukin-1 gene polymorphisms with Alzheimer’s disease. Ann Neurol 47, 365–368 (2000). · doi:10.1002/1531-8249(200003)47:3<365::aid-ana13>3.0.co;2-g

Cited by

See all 5

Metadata

Authors
Novak, J., Zamostna, B., Vopalensky, V., Buryskova, M., Burysek, L., Doleckova, D., & Pospisek, M.
Affiliations
  • Charles University (CZ)
  • Protean (Czechia) (CZ)
Venue
Scientific Reports
Published
2020-04-24
Volume
10
Issue
1
Pages
6995-6995
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3020073795
Cited by
3
References
86
Citations by year
2025: 1 · 2020: 2
FWCI
0.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Univerzita Karlova v Praze (SVV 260568)
  • European Regional Development Fund (CZ.1.05/4.1.00/16.0347, CZ.2.16/3.1, LM2015062, CZ.2.16/3.1.00/21515)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
interleukin-1 alpha, p53, protein-protein interaction, DNA damage, genotoxic stress, etoposide, tumor suppression, intracellular signaling
MeSH terms
Cytoplasm, DNA Damage, HeLa Cells, Humans, Microscopy, Fluorescence, Blotting, Western, Tumor Suppressor Protein p53, Immunoprecipitation, Interleukin-1alpha, DNA Breaks, Double-Stranded

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-1α associates with the tumor suppressor p53 following DNA damage. https://app.cochat.ai/papers/10.1038/s41598-020-63779-x
The paper
Novak, J., Zamostna, B., Vopalensky, V., Buryskova, M., Burysek, L., Doleckova, D., & Pospisek, M. (2020). Interleukin-1α associates with the tumor suppressor p53 following DNA damage. Scientific Reports. https://doi.org/10.1038/s41598-020-63779-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.